Primary Site >> Colorectal Cancer
Gene >> CX3CR1
|
|
|
|
|---|---|---|---|
|
Ref: Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients. PMID: 17611763 |
Ref: The use of hypoxic cultured mesenchymal stem cell for oncolytic virus therapy. PMID: 23618949 Ref: Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis. PMID: 24245985 |
Ref: The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination. PMID: 26673138 Ref: Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. PMID: 27096098 |
Ref: Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy. PMID: 28691930 Ref: Targeting CXCR4-dependent immunosuppressive Ly6C(low) monocytes improves antiangiogenic therapy in colorectal cancer. PMID: 28900008 |